The antecedents of biliary cancer: a primary care case-control study in the United Kingdom

被引：68
作者：
Grainge, M. J. [1 ]
West, J. [1 ]
Solaymani-Dodaran, M. [1 ,3 ]
Aithal, G. P. [2 ]
Card, T. R. [1 ]
机构：
[1] Univ Nottingham, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England
[2] Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2UH, England
[3] Shaheed Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran
来源：
BRITISH JOURNAL OF CANCER | 2009年 / 100卷 / 01期
关键词：
cholangiocarcinoma; gall bladder cancer; risk factors; non-steroidal anti-inflammatory drugs; database study; PRACTICE RESEARCH DATABASE; RISK-FACTORS; EXTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER CANCER; TRENDS; SURVIVAL; SURGERY;
D O I：
10.1038/sj.bjc.6604765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In a case-control study using a large UK primary care database, we found that non-steroidal anti-inflammatory drugs had no protective effect against biliary carcinomas (cholangiocarcinoma and gall bladder cancer). Increased risks were observed for cigarette smoking, diabetes, gallstone disease and obesity.
引用
收藏
页码：178 / 180
页数：3
相关论文
共 16 条
[1]  
Clary BM, 2007, J GASTROINTEST SURG, V11, P1496
[2]   Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy [J].
Donato, F ;
Gelatti, U ;
Tagger, A ;
Favret, M ;
Ribero, ML ;
Callea, F ;
Martelli, C ;
Savio, A ;
Trevisi, P ;
Nardi, G .
CANCER CAUSES & CONTROL, 2001, 12 (10) :959-964
[3]   RISK OF EXTRAHEPATIC BILEDUCT CANCER AFTER CHOLECYSTECTOMY [J].
EKBOM, A ;
HSIEH, CC ;
YUEN, J ;
TRICHOPOULOS, D ;
MCLAUGHLIN, J ;
LAN, SJ ;
ADAMI, HO .
LANCET, 1993, 342 (8882) :1262-1265
[4]  
Hollowell J, 1997, Popul Trends, P36
[5]   Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database [J].
Langman, MJS ;
Cheng, KK ;
Gilman, EA ;
Lancashire, RJ .
BRITISH MEDICAL JOURNAL, 2000, 320 (7250) :1642-1646
[6]   Trends in survival after surgery for cholangiocarcinoma: A 30-year population-based SEER database analysis [J].
Nathan, Hari ;
Pawlik, Timothy M. ;
Wolfgang, Christopher L. ;
Choti, Michael A. ;
Cameron, John L. ;
Schulick, Richard D. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (11) :1488-1496
[7]  
Serra I, 1996, CANCER, V78, P1515, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1515::AID-CNCR21>3.3.CO
[8]  
2-#
[9]   Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A hospital-based case-control study [J].
Shaib, Yasser H. ;
El-Serag, Hashem B. ;
Nooka, Ajay K. ;
Thomas, Melanie ;
Brown, Thomas D. ;
Patt, Yehuda Z. ;
Hassan, Manal M. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (05) :1016-1021
[10]   Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies [J].
Sirica, AE ;
Lai, GH ;
Zhang, ZC .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (04) :363-372
12